The production of vitamin C in Jiangshan was completely stopped in mid-May 2023 dsm-firmenich has recently sold its complete equity interest in DSM Jiangshan Pharmaceutical to Jingjiang Cosfocus Health Technology China. In June 2023, dsm-firmenich announced its plan to restructure its vitamin assets to reduce significant costs. As a part[Read More…]
